Home
Conditions
Respiratory Tract Neoplasms

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,063 public trials 1,834 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer

NCT05566041

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Small Cell Lung, +8 more
Locations: H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States

The University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Active, Not Recruiting

Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

NCT03769103

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +15 more
Locations: BC Cancer, Vancouver Centre Vancouver, British Columbia, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

LDCT Screening in Non-smokers in Taiwan

NCT02611570

Conditions: Behavior, Lung Cancer, Lung Diseases, +10 more
Locations: Chiayi Chang Gung Memorial Hospital Chiayi City, Taiwan

Hualien Tzu Chi Hospital Hualien City, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan

View all 17 locations

View Trial Details

Active, Not Recruiting

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

NCT03075072

Conditions: Adenocarcinoma, Brain Diseases, Brain Metastases, +40 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC

NCT05400070

Conditions: Anlotinib, Chemotherapy, Lung Cancer, +8 more
Locations: Tangdu Hospital, the Air Force Military University Xi'an, China

View Trial Details

Active, Not Recruiting

Improving Utilization of Lung Cancer Screening in Underserved PA Populations

NCT04806399

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Lehigh Valley Health Network Allentown, Pennsylvania, United States

Jefferson Health System Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

NCT05620134

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +86 more
Locations: Institut Jules Bordet Brussels, Belgium

UZA Edegem, Belgium

UZ Ghent Ghent, Belgium

CHU UCL Namur - site Godinne Yvoir, Belgium

View Trial Details

Active, Not Recruiting

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

NCT05215574

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +83 more
Locations: NGM Clinical Study Site Gilbert, Arizona, United States

NGM Clinical Study Site Los Angeles, California, United States

NGM Clinical Study Site Sarasota, Florida, United States

NGM Clinical Study Site Tampa, Florida, United States

View Trial Details

Active, Not Recruiting

National Register Studies in Thoracic Surgery

NCT03567538

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +7 more
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details

Active, Not Recruiting

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

NCT03546426

Conditions: Adenoma, Advanced Cancer, Disease Attributes, +18 more
Locations: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy

View Trial Details

Respiratory Tract Neoplasms

Respiratory Tract Neoplasms trial results

Related conditions